[Role of hepatic lipases, cholesterol ester transfer proteins and LCAT in the postprandial phase]
- PMID: 2087075
[Role of hepatic lipases, cholesterol ester transfer proteins and LCAT in the postprandial phase]
Abstract
Hepatic, heparin-releaseable lipase is a multifunctional enzyme that may act on all lipoprotein classes present in plasma from fasted subjects. Recent evidence suggests that the enzyme also plays a role in the metabolism of chylomicronremnants. Its activity is impaired in normolipidemic patients with coronary heart disease, which also have a delayed removal of chylomicronremnants from plasma. Therefore hepatic lipase, in addition to lipoprotein lipase, plays an important role in postprandial lipoprotein metabolism. The activity levels of lecithin: cholesterol acyltransferase (LCAT) and cholesterylester transfer protein (CETP) are virtually unchanged after the ingestion of an oral fat load by normolipidemic subjects. However, the net mass transfer of cholesterylesters out of HDL into apo B-containing lipoproteins (chylomicronremnants, VLDL/IDL/LDL) is strongly increased. All triglyceride-rich lipoprotein fractions accumulate postprandially and, as a result of CETP action, become enriched in cholesterylesters. Defects in hepatic remnant removal may result in influx of remnants into the arterial wall. In patients with hyperlipidemia (and increased risk for atherosclerosis) the CETP-mediated formation of cholesterylester-rich remnants may operate, not only during the postprandial phase, but continuously.
Similar articles
-
In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.Atherosclerosis. 1998 Dec;141(2):209-25. doi: 10.1016/s0021-9150(98)00169-5. Atherosclerosis. 1998. PMID: 9862170
-
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.Clin Lab. 2003;49(11-12):601-13. Clin Lab. 2003. PMID: 14651331 Review.
-
Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.Artery. 1993;20(1):1-18. Artery. 1993. PMID: 8447724
-
[Recent advanced knowledges related with lipoprotein metabolism].Nihon Rinsho. 1999 Dec;57(12):2717-22. Nihon Rinsho. 1999. PMID: 10638202 Review. Japanese.
-
Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.Atherosclerosis. 1993 Jan 4;98(1):33-49. doi: 10.1016/0021-9150(93)90221-f. Atherosclerosis. 1993. PMID: 8457249
Cited by
-
Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.Clin Investig. 1994 Jul;72(7):502-7. doi: 10.1007/BF00207478. Clin Investig. 1994. PMID: 7981577 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous